Oncology Brothers

Lung Cancers Today

<p>In this special episode, The Oncology Brothers focus on the center of personalized medicine: the patient. Patient advocate and lung cancer survivor Jill Feldman details her lung cancer journey, from early-stage disease to advanced stage with metastases. Jill, who is a co-founder of the EGFR Resisters, an advocacy group that aims to improve outcomes for people with EGFR-positive lung cancer, speaks about how novel therapies have provided her with the opportunity to live out her life and spend quality time with loved ones.</p>


Laura Litwin

How Stigma Undermines Mental Health in Young Patients With Lung Cancer

Lung Cancer

Stephen V. Liu, MD

Cecilia Brown

IMFORTE and DeLLphi-304: Dr. Stephen Liu Unpacks New Data in SCLC

Small Cell Lung Cancer

New Recommendations Spotlight Exercise-Based Interventions to Boost Function in Patients With Lung Cancer

CAMPASS: Benmelstobart Plus Anlotinib Shows Superior PFS in PD-L1 Positive Advanced NSCLC

Non-Small Cell Lung Cancer

Ken Culver, MD

ALK Positive at ASCO 2025: Ken Culver, MD, Reflects on Experiences, Importance of Patient Advocacy

ASCO 2025

SACHI: Savolitinib Plus Osimertinib Prolongs PFS Versus Chemotherapy in MET-Driven EGFR-Mutated NSCLC

EGFR+ NSCLC

Latest News

Lung Cancer Survivor Jill Feldman Offers Hope With Her Journey

Jill Feldman, a lung cancer survivor and co-founder of the EGFR Resisters advocacy group, discusses how novel therapies have provided her with the opportunity to live out her life.